Novartis Oncology
- Our Company
- Novartis Oncology
Bold in our pursuit to reimagine medicine
Novartis Oncology is inspired by patients to revolutionize the research, development and manufacturing of innovative, high quality medicines that help to improve and extend people’s lives.
Novartis at EHA
Novartis is virtually present at the 25th European Hematology Association (EHA) Annual Congress.
Novartis at ASCO
Latest oncology resources and news surrounding Novartis data featured at American Society of Clinical Oncology (ASCO).
Reimagining cancer in the workplace
Novartis is strongly committed in helping and supporting employees impacted by cancer through the global workplace program Ensemble – Caring for Colleagues.
Learn about AI in cancer research
Artificial intelligence decodes cancer pathology images
Our scientists are breaking through the barriers to transform cancer care and reimagine medicine.
"Cancer is a chapter in history we will rewrite. Novartis is positioned to reimagine cancer and transform the lives of patients around the world."
-
25+
Conditions treated worldwide
-
30
New molecular entities in our global clinical pipeline
Learn about Novartis immuno-oncology research
Immuno-oncology researchers seek to build smart drug combos
Stay up-to-date on Novartis Oncology news and stories.
When science and passion connect, innovation happens. Join us.
- Sales Specialist – Oncology/Hematology – Cincinnati – Remote
Cincinnati, OH, USA
- Global Technical Steward – Technology Transfer (Expert)
Colleretto Giacosa, Italia
- Director, Medical Ops Program Management (Medical Meetings, FMV, MSAs)
East Hanover, NJ, USA
- Head Market Access & Public Affairs, Oncology
Rotkreuz, Switzerland
